A detailed history of Pegasus Asset Management, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Pegasus Asset Management, Inc. holds 42,469 shares of EW stock, worth $3.09 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
42,469
Previous 43,287 1.89%
Holding current value
$3.09 Million
Previous $4 Million 29.91%
% of portfolio
0.85%
Previous 1.24%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$59.7 - $93.78 $48,834 - $76,712
-818 Reduced 1.89%
42,469 $2.8 Million
Q2 2024

Jul 25, 2024

BUY
$84.3 - $94.31 $48,809 - $54,605
579 Added 1.36%
43,287 $4 Million
Q1 2024

May 02, 2024

SELL
$72.54 - $95.56 $5,005 - $6,593
-69 Reduced 0.16%
42,708 $4.08 Million
Q4 2023

Feb 08, 2024

BUY
$61.71 - $77.76 $64,733 - $81,570
1,049 Added 2.51%
42,777 $3.26 Million
Q3 2023

Nov 02, 2023

BUY
$69.28 - $93.38 $13,578 - $18,302
196 Added 0.47%
41,728 $2.89 Million
Q2 2023

Aug 01, 2023

SELL
$81.41 - $94.33 $20,433 - $23,676
-251 Reduced 0.6%
41,532 $3.92 Million
Q1 2023

Apr 21, 2023

SELL
$74.26 - $84.51 $4,529 - $5,155
-61 Reduced 0.15%
41,783 $3.46 Million
Q4 2022

Jan 25, 2023

BUY
$68.3 - $87.44 $19,738 - $25,270
289 Added 0.7%
41,844 $0
Q3 2022

Nov 08, 2022

SELL
$82.37 - $107.29 $45,468 - $59,224
-552 Reduced 1.31%
41,555 $3.43 Million
Q2 2022

Aug 01, 2022

SELL
$86.5 - $128.27 $106,741 - $158,285
-1,234 Reduced 2.85%
42,107 $4 Million
Q1 2022

Apr 20, 2022

SELL
$101.96 - $128.34 $36,093 - $45,432
-354 Reduced 0.81%
43,341 $5.1 Million
Q4 2021

Jan 18, 2022

BUY
$106.37 - $130.68 $25,847 - $31,755
243 Added 0.56%
43,695 $5.66 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $2,572 - $3,068
-25 Reduced 0.06%
43,452 $4.92 Million
Q2 2021

Jul 29, 2021

SELL
$83.84 - $104.76 $17,522 - $21,894
-209 Reduced 0.48%
43,477 $4.5 Million
Q1 2021

Apr 28, 2021

BUY
$78.68 - $90.67 $111,646 - $128,660
1,419 Added 3.36%
43,686 $3.65 Million
Q4 2020

Jan 15, 2021

BUY
$71.69 - $91.23 $3,226 - $4,105
45 Added 0.11%
42,267 $3.86 Million
Q3 2020

Oct 13, 2020

BUY
$67.19 - $87.44 $6,786 - $8,831
101 Added 0.24%
42,222 $3.37 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $1.61 Million - $2.15 Million
28,004 Added 198.37%
42,121 $2.91 Million
Q1 2020

Apr 27, 2020

BUY
$52.41 - $81.0 $7,966 - $12,312
152 Added 1.09%
14,117 $2.66 Million
Q4 2019

Jan 22, 2020

SELL
$71.7 - $82.09 $13,551 - $15,515
-189 Reduced 1.34%
13,965 $3.26 Million
Q3 2019

Oct 31, 2019

BUY
$61.55 - $75.43 $2,646 - $3,243
43 Added 0.3%
14,154 $3.11 Million
Q2 2019

Aug 05, 2019

SELL
$55.74 - $64.41 $278 - $322
-5 Reduced 0.04%
14,111 $2.61 Million
Q1 2019

Apr 24, 2019

SELL
$47.89 - $64.05 $10,535 - $14,091
-220 Reduced 1.53%
14,116 $2.7 Million
Q4 2018

Feb 12, 2019

SELL
$46.41 - $56.94 $3,248 - $3,985
-70 Reduced 0.49%
14,336 $2.2 Million
Q3 2018

Nov 05, 2018

BUY
$45.7 - $58.03 $43,506 - $55,244
952 Added 7.08%
14,406 $2.51 Million
Q2 2018

Jul 27, 2018

BUY
$42.45 - $51.3 $29,927 - $36,166
705 Added 5.53%
13,454 $1.96 Million
Q1 2018

May 01, 2018

SELL
$37.19 - $47.45 $7,809 - $9,964
-210 Reduced 1.62%
12,749 $1.78 Million
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $437,884 - $510,455
12,959
12,959 $1.46 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Pegasus Asset Management, Inc. Portfolio

Follow Pegasus Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Asset Management, Inc. with notifications on news.